PROVIDER PROFILE · NPI 1134313802
Valerie SmithDO
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
843
Beneficiaries
—
Total drug cost
$29K
Distinct drugs
32
Brand share
19.7%
Top prescribed drugs
Levothyroxine Sodium90 claims
Rosuvastatin Calcium58 claims
Losartan Potassium56 claims
Lisinopril56 claims
Amlodipine Besylate56 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$131
Payment records
5
By payment type
Food and Beverage$131
Top paying entities
Food and Beverage$131
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
REFERRAL NETWORK
Where Valerie Smith's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 5 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| PROVIDENCE HEALTH & SERVICES WASHINGTON | 16 | 54 |
| Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Seattle, WA | 11 | 37 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| PATHOLOGY ASSOCIATES MEDICAL LABORATORIES LLC | 40 | 237 |
| NPI 1831144278 | 15 | 62 |
| Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Seattle, WA | 14 | 30 |
| PROVIDENCE HEALTH & SERVICES WASHINGTON | 14 | 62 |
| NPI 1255303376 | 11 | 20 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE